Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial

European Respiratory Journal

Volumn 13, Issue 2, 1999, Pages 238-246

  Tonnesen P ^a   Paoletti, P ^b   Gustavsson, G ^c   Russell, M A ^d   Saracci, R ^e   Gulsvik, A ^f   Rijcken, B ^g   Sawe, U ^c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b ELI LILLY   (United States)

^c Pharmacia & Upjohn AB   (Sweden)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Dose; Duration; Nicotine patches; Smoking cessation

Indexed keywords

NICOTINE; NICOTINE GUM;

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEADACHE; HEART INFARCTION; HEART PALPITATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NIGHTMARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TACHYCARDIA; TRANSDERMAL DRUG ADMINISTRATION; VOMITING; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; BODY WEIGHT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PATIENT COMPLIANCE; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 0032979241     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13b04.x     Document Type: Article

References (31)

1. Silagy C, Mant D, Fowler G, Lancaster T. The effect of nicotine replacement on smoking cessation. In: Lancaster T, Silagy C, Fullerton D, eds. Tobacco Addiction Module of the Cochrane Database of Systematic Reviews. Oxford, The Cochrane Collaboration. 1997; pp. 1-18.
2. Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992; 44(3): 498-529.
3. Stapleton JA, Russell MAH, Feyerabend C, et al. Dose effects and predictors of outcome in a randomised trial of nicotine patches in general practice. Addiction 1995; 90: 31-42.
4. Imperial Cancer Research Fund General Practice Research Group. Randomised trial of nicotine patches in general practice: results at one year. Br Med J 1994; 308: 1476-1477.
5. Daughton DM, Heatley SA, Prendergast JJ, et al. Effect of transdermal nicotine delivery system as an adjunct to low-intervention smoking cessation therapy. Arch Intern Med 1990; 151: 749-752.
6. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. JAMA 1994; 271(24): 1940-1947.
7. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking Cessation. Clinical Practice Guideline No. 18, AHCPR 96-0692. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1996.
8. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. JAMA 1991; 22: 3133-3138.
9. Sachs DPL, Benowitz NL, Bostrom AG, Hansen MD. Percent serum replacement and success of nicotine patch therapy. Am J Respir Crit Care Med 1995; 151: A688.
10. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. IV. Washington D.C., American Psychiatric Association, 1994.
11. Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry 1991; 48: 52-59.
12. Falkman SE, Burrows IE, Lundgren RA, Page BFJ. A modified procedure for determination of nicotine in blood. Analyst 1975; 100: 99-104.
13. Jarvis MJ, Russell MA, Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J 1980; 281: 484-485.
14. Fagerström KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J 1991; 69: 763-768.
15. Freedman LS. Tables of the number of patients required in clinical trials using log-rank test. Stat Med 1982; 1: 121-129.
16. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. 2. Lyon, International Agency for Research on Cancer. 1987; 2: 75-76.
17. The Framingham Study. An Epidemiological Investigation of Cardiovascular Disease. U.S. Department of Health, Education, and Welfare. Public Health Service, National Institute of Health. National Heart and Lung Institute, DHEW publication. No. (NIH)76-1083, April 1976.
18. A report of the Surgeon General. Health consequences of smoking: cardiovascular disease. A report of the Surgeon General. US Department of Health and Human Services. Rockville, MD Public Health Service, Office on Smoking and health. 1983; pp. 63-156.
19. Paoletti P, Fornai E, Maggiorelli F, et al. Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. Ear Respir J 1996; 9: 643-651.
20. Tønnesen P, Nørregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311-315.
21. Nørregaard J, Tønnesen P, Simonsen K, Petersen L, Sawe U. Smoking habits in relapsed subjects from a smoking cessation trial after one year. Br J Addiction 1992; 87: 1189-1194.
22. Nørregaard J, Tønnesen P, Petersen L. Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med 1993; 22: 261-271.
23. Yudkin PL, Jones L, Lancaster T, Fowler GH. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Br J Gen Pract 1996; 46: 145-148.
24. Fiscella K, Franks P. Are nicotine patches cost effective? JAMA 1996; 275: 1247-1251.
25. Jorenby DE, Smith SS, Fiore MC, et al. Varying nicotine patch dose and type of smoking cessation counselling. JAMA 1995; 274: 1347-1352.
26. Dale LC, Hurt RD, Offord KP, Lawson GM, Crogham IT, Schroeder DR. High-dose nicotine patch therapy: percentage of replacement and smoking cessation. JAMA 1995; 274: 1353-1358.
27. Fagerström KO, Schneider NG, Lunell E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatment for tobacco withdrawal symptoms. Psychopharmacology 1993; 110: 251-257.
28. Puska P, Korhonen HJ, Vartiainen E, Urjanheimo EL, Gustavsson G, Westin A. Combined use of nicotine patch and gum compared with gum alone in smoking cessation: a clinical trial in North Karelia. Tobacco Control 1995; 4: 231-235.
29. Kornitzer M, Boutzen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995; 24: 41-47.
30. Sachs DPL, Benowitz NL. Individualizing medical treatment for tobacco dependence. Eur Respir J 1996; 9: 629-631.
31. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195-1202.